Medicare Enrolled

Dr. Robert Gerstenbluth, MD

Urology Physician · Schenectady, NY
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
2200 ROSA RD, Schenectady, NY 12309
5183743341
In practice since 2006 (20 years)
NPI: 1326078387 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Gerstenbluth from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Gerstenbluth? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Gerstenbluth

Dr. Robert Gerstenbluth is an urology physician in Schenectady, NY, with 20 years of NPI registration. Based on federal Medicare data, Dr. Gerstenbluth performed 975 Medicare services across 820 unique beneficiaries.

Between the years covered by Open Payments, Dr. Gerstenbluth received a total of $3,033 from 31 pharmaceutical and/or device companies across 132 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urology physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Gerstenbluth is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice ▲ 975 Medicare services $3,033 industry payments

Medicare Practice Summary

Medicare Utilization ↗
975
Medicare services
Bottom 48% in NY for urology physician
820
Unique beneficiaries
$65
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~49 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
333 $45 $147
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
195 $66 $227
Cystourethroscopy
A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract.
103 $57 $373
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
61 $86 $367
Hospital follow-up visit, moderate complexity
Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service.
45 $61 $205
Imaging guidance for procedure, 60 minutes or less
Use of imaging technology to guide a medical procedure. This service lasts 60 minutes or less.
39 $12 $37
Initial hospital admission, moderate complexity
Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter.
31 $100 $387
Endoscopic removal of foreign body, stone, or stent from urethra or bladder
A procedure to remove a foreign object, stone, or stent from the urethra or bladder using an endoscope. The endoscope is a thin tube with a camera inserted into the urinary tract to locate and extract the item.
24 $114 $435
Ureteral stent insertion via endoscope
A flexible tube is inserted into the ureter using an endoscope to keep the passage open and allow urine to flow from the kidney to the bladder.
24 $85 $446
Initial hospital admission, high complexity
Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter.
24 $133 $572
New patient office visit (30-44 min)
An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range.
22 $52 $217
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
20 $110 $314
Ureteral stone crushing with stent insertion
An endoscope is used to break up a stone in the ureter, followed by the placement of a stent to keep the ureter open.
19 $309 $1,103
Imaging of urinary tract with contrast
An imaging test of the urinary tract performed after a contrast agent is injected to enhance visibility of the structures.
18 $19 $50
Limited ultrasound of pelvis
A focused ultrasound exam of the pelvic area to evaluate specific structures. This procedure provides images of the pelvis to assist in medical assessment.
17 $15 $72
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
6.9% high complexity
7.6% medium
85.5% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$3,033
Total received (2018-2024)
Avg $506/year across 6 years
Top 43% in NY for urology physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
31
Companies
132
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$2,920 (96.2%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$114 (3.8%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,003
2023
$450
2022
$667
2021
$259
2020
$124
2018
$531

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Boston Scientific Corporation
$195
Sumitomo Pharma America, Inc.
$158
Astellas Pharma US Inc
$132
Merck Sharp & Dohme LLC
$124
Tolmar, Inc.
$90
Janssen Biotech, Inc.
$85
PFIZER INC.
$52
Teleflex LLC
$51
ABBVIE INC.
$25
Laborie Medical Technologies Corp.
$25
PROCEPT BioRobotics Corporation
$24
Endo Pharmaceuticals Inc.
$23
Axonics, Inc.
$18
Top 3 companies account for 48.4% of 2024 payments
All-time payments by company (2018-2024) ›
Astellas Pharma US Inc
$544
Boston Scientific Corporation
$262
Sumitomo Pharma America, Inc.
$248
UROVANT SCIENCES INC
$211
Endo Pharmaceuticals Inc.
$185
Janssen Biotech, Inc.
$171
Teleflex LLC
$164
Merck Sharp & Dohme LLC
$151
180 Medical, Inc.
$110
Axonics Modulation Technologies, Inc.
$110
Tolmar, Inc.
$108
PFIZER INC.
$104
ABBVIE INC.
$102
BOSTON SCIENTIFIC CORPORATION
$96
TOLMAR Pharmaceuticals, Inc.
$54
Axonics, Inc.
$42
AbbVie, Inc.
$41
Stryker Corporation
$39
Bayer HealthCare Pharmaceuticals Inc.
$36
Rochester Medical Corporation
$35
DENTSPLY IH Inc.
$29
Amgen Inc.
$26
Laborie Medical Technologies Corp.
$25
PROCEPT BioRobotics Corporation
$24
Ferring Pharmaceuticals Inc.
$20
Coloplast Corp
$19
Allergan Inc.
$19
DENTSPLY IH AB
$16
Antares Pharma, Inc.
$15
Mission Pharmacal Company
$15
Avadel Specialty Pharmaceuticals, LLC
$14
Top 3 companies account for 34.7% of all-time payments
Associated products mentioned in payments ›
AQUABEAM SYSTEM · AVEED · Androgel · Axonics · Axonics r-SNM System · BOTOX · BOTOX THERAPEUTIC · Bulkamid · ELIGARD · ERLEADA · Erleada · FIRMAGON · GEMTESA · GENERAL ONCOLOGY · GENTLECATH · GreenLight XPS · KEYTRUDA · LYNPARZA · LoFric · Lupron · MAGIC3 · Myrbetriq · NOCDURNA · Noctiva · Optilume BPH Drug Coated Balloon Catheter · PRECISION AC HD ENDOSCOPIC CAMERA · PVC · SpaceOAR VUE System - 10mL · SpeediCath · UROLIFT · UroLift System · Urocit-K · Veozah · XGEVA · XIAFLEX · XTANDI · Xofigo · Xtandi
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (96%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for an urology physician in Schenectady?
Compare urology physicians in the Schenectady area by procedure volume, costs, and industry payment transparency.
Browse urology physicians nearby

Geographic Context

Urology physicians within 10 mi
52
Per 100K population
32.6
County median income
$76,989
Nearest hospital
ELLIS HOSPITAL
3.2 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Gerstenbluth is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement, with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Gerstenbluth experienced with office visit, established patient (20-29 min)?
Based on Medicare claims data, Dr. Gerstenbluth performed 333 office visit, established patient (20-29 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Gerstenbluth receive payments from pharmaceutical companies?
Yes. Dr. Gerstenbluth received a total of $3,033 from 31 companies across 132 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Gerstenbluth's costs compare to other urology physicians in Schenectady?
Dr. Gerstenbluth's average Medicare payment per service is $65. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Gerstenbluth) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →